Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
HUGE banking news for weeds!! IN FSPM MJNA GWPRF PLPL...check this news:
Federal Government To Let Banks Work With Marijuana Businesses ...
www.theweedblog.com/federal-government-to-let-banks-work-with-mar...?
12 hours ago - There was a lot of big marijuana news that occurred this week, but the biggest news came out of ... Banking has been a major issue for the marijuana industry. ... I'm curious how this will affect loans to marijuana businesses.
I'll guess there will be a big time run in weed stocks today....and the bad overall market may even accentuate the moves higher because the weed sector may be about the only sector "green"...so to speak! Just all imho...good luck to all...tuna
Also impressive writeup on SPCB $6.66 +.02 yesterday:
SuperCom Path To $250M In Revenues By 2018
Jan. 22, 2014 2:27 PM ET | 1 comment | About: SPCB
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)
SuperCom (SPCB) is a relatively unheard-of name. I suggest you read the excellent piece by Lazarus Investment Partners, which had the pleasure of interviewing the company's CEO. SuperCom is an Israeli company that operates in the RFID (radio frequency identification), and the e-ID (electronic ID) markets. Last week, an interview with Arie Trabelsi, the company CEO and major shareholder, caught my eye. Trabelsi has been leading SuperCom since 2010, when Sigma Wave, another company Trabelsi owns, acquired SuperCom's debt for a few million dollars. That debt was eventually converted to shares, and Trabelsi became the majority owner of SuperCom. A number of things got me to thinking that SuperCom might be a true gem. In this article I'll explain why I think you should definitely get to know the SuperCom name. I will also suggest a model that will enable you to follow the company in the coming years and tell if it is on course to achieve $250M in revenues by 2018 as Trabelsi suggests. So, what's the story with SuperCom?
1. An Impressive Turnaround
Usually, when CEOs make rosy declarations in the media, I would like to see their past record. SuperCom was a losing company up until Trabelsi took the company's reins. Initially, the financial situation was harsh.
(click to enlarge)
Source: SuperCom Investor Presentation
As you can see, it took the new management four quarters to turn the company around and bring it back to profitability. That is while revenues were pretty flat q/q. In my view, this is a sign of impeccable management skills and great execution of the turnaround plan.
(click to enlarge)
In Q2-13 the company reported shareholders equity was $4.8M, and working capital was $3.13M.
2. Trabelsi Has Ambitious Plans
In his interview, Trabelsi said he plans to achieve revenues of $250M by 2018. After the recent acquisition of the e-ID division of On Track Innovation (OTIV), SuperCom put forth a pro-forma estimation of the 2012 results of the combined entity.
(click to enlarge)
As you can see, in 2012 the combined entity had revenues of $26.3M. That means that Trabelsi aims to grow the business by a factor of almost 10 above 2012 levels. He plans to do so by 2018. You don't see a lot of CEOs that go forth and set such ambitious goals. Are Trabelsi's goals sustainable? What's the path to $250M? We'll come back to that shortly.
3. SuperCom Is Still Undervalued
SuperCom's shares traded at $6.81 a share (as of Friday the 17th), and according to a recent press release, for 2013, the first six months' net income was $4.12M. That means that the company is on the path of achieving a net income of ~$8.6M and an EPS of $0.66. That gives the company a P/E of about 10. If Trabelsi's goals are to be materialized, and SuperCom will start enjoying a recurring revenue stream from e-ID contract wins, SuperCom should grow its bottom line in very high double-digit rates. Giving the company a PEG of 1 will require a much higher PE than 10 (in the 30-40 range). Thus, I believe that even after the recent stock price appreciation, the company is still cheap.
4. Balance Sheets Are Clean
As of June 2013, SuperCom had $6.9M in current assets. The company has only a $81K short term bank debt. With a shareholders' equity of $4.8M and a working capital of $3.7M, the company looks like it is financially sound. While the current financial situation might prevent SuperCom from winning certain large contracts, with rapid growth rates expected, this will quickly change.
The Path toward $250M
Dilution
Assuming that SuperCom will make two more acquisitions in the next five years, I got to the following:
In the next five years, SuperCom will acquire two businesses, each with $10M in revenues.
I assume SuperCom will pay $15M-$20M for each business.
Until SuperCom's pockets get deeper, it probably won't have a lot of access to bank debt. In that case, SuperCom will raise the required funds through secondary offerings.
Assuming the first offering will be at $6 a share, and the second one at $8 a share, we are facing an additional dilution of about 5M shares in the worst-case scenario.
Taking into account that 5M dilution, the company will have 18M shares in 2018.
I wanted to add this assumption to the model to get ready for the worst-case scenario, dilution-wise.
The 2014 revenue figure is based on the notion that SuperCom will win three contracts in 2014. In the Lazarus-Trabelsi interview, Trabelsi mentioned that the sizes of contracts vary between $5M and $150M. Assuming $15M per contract, winning three contracts in 2014 should bring SuperCom to a run rate of $70M/year.
Assuming a CAGR of 50% and decelerating growth, the path to $250M in revenues might look like this:
Year 2014 2015 2016 2017 2018
Revenues
$70M $120M $180M $220M $250M
Growth Rate 133% 71.43% 50% 22.22% 13.46%
According to the Trabelsi interview with Lazarus Investment Partners, SuperCom management believes such growth is possible with organic growth alone. I took the conservative side and assumed two more acquisitions. SuperCom inherited a pipeline from OTI of bids in more than 20 countries around the world. Management expects to win a few contracts in 2014. This will be crucial to the company. According to the above model, SuperCom needs to win at least three big contracts a year in the e-ID business. So, this will be a very easy way of following the company's success. Looking into 2014, if SuperCom is to achieve their goals, we need to see a contract win within the April timeframe.
Don't Be Confused by Financial Income
The first six months of the 2013 results are showing $3M in tax benefits in comparison with $1.1M of income before tax. This might confuse investors. While tax benefits are without a doubt an asset, I don't like to base valuation upon big, non-operational items. SuperCom is showing that the combined entity had a net income of $4.6M in 2012, representing 38% of revenues. Just to be on the safe side of things, I'll assume a 30% net income margin, to make sure I'm not including any financial income in my model.
Valuation
When taking all of the above together, and taking a P/E of 15, I came up with:
Year 2014 2015 2016 2017 2018
Net Income $21M $36M $54M $66M $75
Diluted Shares 18M 18M 18M 18M 18M
EPS $1.17 $2 $3 $3.67 $4.17
Share Price $17.5 $30 $45 $55 $62.5
You can't afford to ignore these numbers. This is the potential reward you can get by riding along with Trabelsi and SuperCom. Of course, the reward is only one side of any investment. What's the risk?
The Risk
Let's take the possibly worst-case scenario. That would be that Trabelsi turns out to be a dreamer and nothing of his plans ever gets realized. So, what might SuperCom's shares be worth in that scenario? Let's say that the combined SuperCom & OTI show 0% growth in 2013 and 2014. Revenues are $26M and net income is $8M (ignoring any tax benefits). An amount of $8M in net income equals to $0.62 in EPS (taking 13M shares). Let's say the company stays under the radar and the market gives the company a low P/E of 9.
SPCB PE Ratio (<a href=
SPCB PE Ratio (TTM) data by YCharts
Applying those numbers gives us a stock price of $5.58 per share. That's a downside of 18.4% from Friday's closing price of $6.81.
Looking at both scenarios, the reward (2014 share price) is 8.5 times bigger than the risk. Not a risk/reward profile you stumble upon every day.
Conclusion
This could be a very interesting investment for those of you who can handle this level of risk. This will not be a gradual growing of the business, but rather a jumpy ride. I wanted to give you, the investors, both possible sides of this play. It is of the upmost importance to do your due diligence and know what factors affect the business you invest in. I hope that with the actual modeling of Mr. Trabelsi's goals, I have supplied you with a tool that you can refer to when you want to see if the company is on/off track. You know how many/how often contract wins should be reported each year, so you know what to expect from the company. Right now the goals are clear, and Trabelsi has proven he can live up to his goals in his turnaround of the company over the past two years. Will Trabelsi lead SuperCom to join the elite club of 10-baggers? Only the future will tell. You know the risks, and you know the potential reward. Choose and invest wisely.
This article was sent to 303 people who get email alerts on SPCB.
GL all...tuna
Added MJNA .25 - .26 on pullback, after seeing this BIG news on it:
Medical Marijuana Inc., 4th Quarter 2013 Corporate Update: HempMedsPX Has 500% Revenue Increase - Division and Corporate Holdings Update
Company's Divisions' Growth Includes Investing in Local Manufacturers, Distributors, Brands and Dot Coms; Public Awareness of Industrial Hemp-Based Cannabidiol (CBD) Products Created With Mainstream News Media Coverage and Community Outreach
GlobeNewswire Medical Marijuana Inc
January 22, 2014 9:00 AM
SAN DIEGO, Jan. 22, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (MJNA), a leading cannabis and industrial hemp industry innovator, is pleased to inform shareholders that Company divisions continued to increase revenues significantly. With the close of the fourth quarter of 2013, the Company had a gross income of approximately $8.07 million. The most significant increase in revenue came from direct product sales through HempMedsPX, which increased revenues by over five hundred (500%) percent, or $1.06 million, with a gross income of over $1.31 million. Updates are provided for each of our portfolio companies and investments. New product launches, continued market penetration, product advertising in mainstream media and key business agreements with wholesalers, distributors and resellers of innovative industrial hemp-based cannabidiol (CBD) products are fostering exponential growth.
Medical Marijuana Inc. is proud to announce an update on current events in advance of its official, detailed quarterly and annual reports.
CanChew Biotechnologies -- In the United States, CanChew CBD-rich hemp oil gum is available for purchase online. Each piece contains approximately 10 mg of naturally-derived industrial hemp-based cannabidiol (CBD). In the fourth quarter, the Company continued to gain market traction and public awareness while it finalized its clinical development plans. The Company is focusing on establishing celebrity and medical professional endorsements in the near future, as well as developing additional product distribution channels. In addition, CanChew Biotechnologies has established an independent board of directors and management committee.
Canipa Holdings -- Established to administer the marketing, sales, and distribution of Medical Marijuana Inc.'s portfolio of products throughout Europe and the European Free Trade Association (EFTA) participant counties. Canipa Holdings has a distribution network of pharmacies, clinics, wellness centers and retail stores in EFTA countries, and plans to offer MJNA's full line of products. The Company continued European expansion by signing additional distributors for HempMedsPX. Canipa Holdings continues to work with government officials on product approval, medical cannabis and industrial hemp approvals in Europe.
The Company has also expanded its operations to include a team dedicated to the Caribbean Islands.
HempMedsPX -- HempMedsPX, a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc., was established to develop online platforms for the marketing and sales of hemp-based consumer products. The Company continues actively acquiring, developing, securing IP, adding additional online properties, and acquiring marketing and brand awareness partners.
In order to meet the growing demand for the cannabidiol (CBD)-rich hemp oil products that HempMedsPX markets, represents and distributes, the Company increased staff in the areas of: outside sales, customer service, software and programming, website development, video production, public relations, compliance and community outreach.
HempMedsPX launched new Cibdex and HempVAP websites featuring hemp-based cannabidiol (CBD)-rich tincture drops and HempVAP, the world's first hemp-based CBD vaporizer product. The full line of products that HempMedsPX represents currently includes:
CanChew
Real Scientific Hemp Oil
Cibaderm
Cibdex
HempVAP
The Company participated in major cannabis industry events and continued its strategic marketing campaigns to increase awareness of CBD-rich hemp oil products in the public. Participating in this aggressive trade show schedule resulted in unprecedented interest in the products that HempMedsPX represents, and propelled the significant increase in revenue in the fourth quarter. Events included:
Miami Wholesale Expo - Miami, FL: Sept. 30-Oct. 2
Ohio Rights Group Tour: Oct. 10-20
Ultimate Women's Expo - Phoenix, AZ: Oct. 19-20
Champs -- Denver, CO: Oct. 22-24
International Spa Association (ISPA) - Las Vegas NV, Mandalay Bay: Oct. 22-24
DPA Conference - Denver, CO: Oct. 23-26
LA Ultimate Women's Expo - Los Angeles, CA: Oct. 26-27
2nd Annual Marijuana Business Conference & Expo - Seattle, WA: Nov 6-8
San Francisco Green Festival - San Francisco, CA: Nov. 9-10
Michigan Medical Marijuana Trade Show: Nov. 15-17
SOHO Natural Products Expo - Orlando FL: Dec. 5-8
High Times Cannabis Cup - Amsterdam, The Netherlands: Dec. 3
American Academy of Anti-Aging Medicine (A4M) - Las Vegas, Dec. 12-15
As part of the Company's strategic plan to increase visibility of industrial hemp-based CBD oil products with the public, the Company gained print, online, social media, television and radio coverage throughout the fourth quarter of 2013. To further awareness and brand recognition, Brand Ambassador, Cheryl Shuman, was retained in October, 2013. Awareness creation of the diverse product lines that HempMedsPX represents were featured in mainstream media including:
BBC
CNBC
Geraldo at Large
Univision
Fox 31 Denver
NBC Cincinnati
Robert Scott Bell radio show (archives available on iTunes, NaturalNews.com and GCN.com)
Danielle Lin radio show
Medical Jane (product reviews)
Ohio Free Press
THC Connoisseur (product review)
ERB magazine
ABC News
HempMedsPX represented the winner of the world-renowned 2013 Seattle High Times Cannabis Cup award, 2013 Amsterdam Cannabis Cup award, and 2013 Michigan Medical Marijuana Conference "Green Cup" contests for Highest (hemp) CBD Concentrate.
Corporate goodwill was extended through the Company's first multi-state community outreach initiative in support of its customers, families and individuals in need. These outreach endeavors are ongoing.
HempMedsPX continues to educate the general public that the CBD-rich hemp oil products that the company represents:
are available for people of all ages
are available for animals
can be purchased directly in all 50 states and in more than 40 countries
The Company is working on finalizing celebrity, medical doctor, and industry endorsements to be announced in the near future. HempMedsPX will also be featured in upcoming documentaries in the coming months.
KannaLife Sciences -- KannaLife has spent years in the development of standardization in packaging for cannabis-based products. Standardization of packaging for cannabis-based products is not just a need, but a necessity. The Company looks to set the standard by which the industry will adapt and develop from.
The Company expanded product capabilities, established additional hothouses, and finalized an agreement to access a collection of more than 100,000 extracts from plants, fungi, and bacteria. An agreement with the Natural Product Discovery Institute (NPDI), a division of the Baruch S. Blumberg Institute (BSBI), provides an opportunity for KannaLife Sciences (KannaLife) to access targeted plant species for the identification of novel phytochemicals to treat the diseases of Chronic Traumatic Encephalopathy (CTE) and Hepatic Encephalopathy (HE). This agreement is in place due to the exclusive license agreement with National Institutes of Health -- Office of Technology Transfer (NIH-OTT) for the commercialization of U.S. Patent 6,630,507, "Cannabinoids as Antioxidants and Neuroprotectants" (the "'507 Patent").
Most recently, KannaLife and Salvation Botanicals, Ltd., signed a Memorandum of Understanding centered on the standardization of botanical medicaments and patient wellness in Canada and the United States. Salvation Botanicals, Ltd. is a Canadian provider of high quality and assured botanicals in dried plant and liquid-oral based phyto-extracts. The intended joint venture between KannaLife and Salvation will focus on the expansion of the Salvation Botanicals brand in the United States and the delivery of KannaPak(TM) & C-Dashboard(TM) into the Canadian marketplace.
Red Dice Holdings -- Dixie Botanicals, a brand of Red Dice Holdings, offers innovative CBD-rich hemp oil products for health conscious consumers. Formulation experts include scientists, clinical herbalists, and nutritionists who work to integrate industrial hemp oil into a variety of beneficial and uniquely effective over-the-counter (OTC) products ranging from dietary supplements to a topical balm. Red Dice Holdings also owns the Dixie Elixirs brand of products, which is one of the most prominent cannabis brands in the world, with over 80 products in 5 product categories and has been featured on 60 Minutes, National Geographic, Fox, ABC News, Fortune Magazine, Vice, The Huffington Post and many other industry and mainstream television and publications.
Wellness Managed Services -- The Company finalized a transaction that will allow for staffing and compliance management service contracts to be developed. The company will initially focus on Colorado and Arizona.
"My gratitude goes to our team and loyal shareholders for their continued support. This is an exciting time for the cannabis industry as well as for our company. It has taken years in order to prepare for product development and market positioning in this rapidly growing industry. The products that our team has developed and continues to develop are the first of their kind. We are extremely pleased that these innovative product lines are very well received by the public. As the company grows, we will continue to communicate major announcements to shareholders through news alerts and electronic newsletters," stated Michelle Sides, Chairman and Chief Operating Officer.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com
About Dixie Botanicals (a Red Dice Holdings Brand)
Dixie Botanicals offers innovative hemp oil products for health conscious consumers. Our formulation experts include scientists, clinical herbalists and nutritionists, who work to integrate our hemp oil into a variety of beneficial and uniquely effective over-the-counter (OTC) products-- both dietary supplements and a topical balm. For more information, please visit the company's website: http://dixiebotanicals.com
About HempMedsPX
HempMedsPX offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMedsPX is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the exclusive master distributor and contracted marketing company for CannaVest Corp. (CANV) and Medical Marijuana Inc. In addition to handling sales and distribution, HempMedsPX is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About KannaLife Sciences
KannaLife Sciences ("KannaLife"), is a late stage bio-pharmaceutical and phyto-medical technology company. We were created to develop natural, phyto-medical products to be used in health and wellness regimens. We are also involved in the research and development of novel new therapeutic agents to be used as transport carriers for other compounds seeking to break the blood/brain barrier as well as our own compounds to be used for the treatment and prevention of oxidative and neuro-toxic stresses born from a variety of ailments and illnesses. For more information, please visit the company's website at: www.Kannalife.com
About Cheryl Shuman
Cheryl Shuman's TV reality started at age three with Charles Kuralt. By age seventeen, she had made several television appearances and was offered to appear regularly on The Bob Braun Show on WLWT-TV in Cincinnati, which led to a national recurring segment on PM Magazine. At age twenty-three, Cheryl relocated to Los Angeles to become know as the "Optician to the Stars" and created a new business, Starry Eyes. As CEO of Starry Eyes, Cheryl worked on some of the biggest films, TV, and music properties generating multi-million dollar revenues. This success led to her own show on the QVC network and a mutually rewarding seven-year relationship that included product placement, production and branded entertainment divisions.
In 2006, Shuman was diagnosed with cancer. After years of following failed allopathic medicine treatments, she opted for medical cannabis in the form of raw juice and oils as an alternative. Her success using medical cannabis led her to found the Beverly Hills Cannabis Club. Today, Cheryl is the most visible and recognizable woman in the medical marijuana reform movement, recently receiving the 2013 Activist of the Year Award at Seattle Hempfest. Together Cheryl and Aimee, her daughter and EVP of Cheryl Shuman, Inc., have reached over 100 million viewers worldwide while appearing on such mainstream shows as CNN's Piers Morgan Live, The Katie Couric Show, The View, ABC's 20/20, Good Morning America, Fox Business News and many other media outlets. Cheryl Shuman is represented by agent Mark Itkin with the prestigious William Morris Endeavor Agency in Beverly Hills. For more information, please visit CherylShuman.com. To contact Cheryl Shuman directly, call (310) 779.4797 or Aimee Nicole Shuman, EVP, at (310) 779.1535.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
LEGAL DISCLOSURE
Medical Marijuana, Inc. and HempMedsPX do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Contact:
For further information, please contact:
Investor relations contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
info@smallcapvoice.com
Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
weed/biotech GWPRF $4.00 w/61mil in cash...43.8 mil revs...just 177.5 mil shares os
This hasn't made a massive move higher in this new year like all the other weeds. But with revenues of $43.8 million, loss of (.05) a share, cash of $61.1 million and debt of only $3.2 million this company has a lot going for it. Well worth reading up on their drug pipeline and sales in Europe and several other countries for one of their drugs. GWPRF trades quite thinly so if it starts drawing any attention, this thing can also take off like all the others in the weed sector!! All in my humble opinion...tuna
Nice close on weed MJNA at .27 and FSPM closed down .07 at $3.10 but a strong recovery from the $2.60's earlier in the morning. SPCB closed $6.66 up just 2 cents but again a nice recovery from $6.20's also....have a good night all and good trading tomorrow....tuna
Added weed MJNA .25 - .26 on pullback. FSPM $3.20 gone "green" wasn't here for the big early selloff in it...ugh! Added TPCS at $1.02 yesterday...cheaper now...gl all!! tuna
Added more SPCB $6.50 upon seeing this very bullish article on it posted a few minutes ago:
day and timesymbolsnews headline and source today
SPCB
SuperCom Path To $250M In Revenues By 2018 at Seeking Alpha Thu 2:27pm
Yes on PLPL and FSPM $3.60 +1.44 what a day!!! Glad I added more at $2.95 but took a loss on CANN...kept PLPL and FSPM. All the best for a great night and a greater tomorrow!! tuna
Added another 1k FSPM at $2.95 on hard pullback from $3.50 HIGH!! CANN back under my buy price now though...tuna
There's $3.00 on FSPM +.84 and at a new 52wk high....staying in it for better or worse....tuna
FSPM $2.85 +.69 new HOD w/$2.95 as 52wk high!!! Smokin'....so to speak! tuna
FSPM $2.55 +.39 new HOD...CANN $18.99 +.98 new HOD!! Also in PLPL .53 here up nicely on the day...tuna
Got some PLPL .53 and CANN $18.60 but took gain in ZDPY...could have done much better on ZDPY but a gain is a gain....still also holding FSPM...so in 3 weeds now. Haha!! tuna
Excellent homey on PLPL...my .475 order hasn't filled...missed by a 1/2 cent...ugh! But ZDPY and FSPM both doing great!! GL luck today!! tuna
ZDPY $3.40 +.40 on good volume for it!! FSPM $2.40 +.24 here also....tuna
FSPM $2.45 +.29 on good volume for this stock!! tuna
Watch ZDPY $3 close up big Fri + FSPM $2.16 up in PM to 2.40!! Like more upside on both of these but note ZDPY float ONLY 800,000 shares!!! GL all....tuna
Yes on PLPL and FSPM and super low float ZDPY $3 close!! Thanks homey....and let's all have a great week!! tuna
Yikes!! ZDPY $4 +$1.75 and ask $4.50 now....fun!!! Hahaha!! tuna
Thanks homey! Got PLPL .49 and got ZDPY at $2.45 and it's over $3 now but careful as the float is only 800K shares....hahaha!! I wouldn't be shocked to see it really fly today!!! But just my simple opinion....GL...tuna
ROCKET!!!! Added ZDPY at $2.45 and already $3.50 bid...ONLY 800K share FLOAT!!! Wow!! What a weed....can it do a CANN??? Hoping so...tuna
Yes PLPL has done very well homey! To offset my loses in a couple of other weeds early in the day however I took a gain on it with while still a bit higher in the morning and will get back in probably tomorrow. For some reason the weeds I follow under a buck sold off hard while some over a dollar surged wildly again???!! Wish I'd had the courage to jump in but did not...I like the sector and PLPL a lot for more upside but with bouts of profit-taking that can be nasty at times. Best of luck in all your stocks and I'll be back in PLPL again very soon again for another profitable move...I hope! tuna
Nice day for SPCB $6.84 +.69 with new 52wk high of $7.03 on over a million shares which is very strong volume for SPCB (sold a few trading shares in high $6.90's)...bright future for this company and will continue to trade in and out of some but always adding on dips. Took a loss in FSPM when it failed to continue higher and a gain on PLPL on seeing it pulling back from nice early gain. Cut back on my MCIG holdings also as the penny weeds performed poorly overall while some like CBDS and CANN continue to SKYROCKET!!!! Wild but without me in them.....ugh!! Have a nice night all and gl tomorrow to us all.....tuna
SPCB $6.88 +.73 on huge volume for it!!!!! Like to see it test $7....trouble posting today....sorry! tuna
SPCB hit $6.74 +.59 another new 52wk high on volume already equaling normal dally average!!!! tuna
Weeds...PLPL .64 +.09 PLPED $6.24 +.99 first day of "green" for PLPED began reversing yesterday but closed down hard...this weed hit a high of $40 in the past week or so!!! Lots of potential upside imho and a very low float stock!! GL all....tuna
Weeds...PLPL .64 +.09 PLPED $6.24 +.99 first day of "green" for PLPED began reversing yesterday but closed down hard...this weed hit a high of $40 in the past week or so!!! Lots of potential upside imho and a very low float stock!! GL all....tuna
Saw SPCB $6.44 +.29 a new high on really big volume for this stock!! tuna
SPCB $6.44 +.29 new high on very strong volume for this high growth low PE stock!! tuna
You're very welcome homey! Like PLPL to test .75 this week....we'll see! I could see it testing a buck within a couple/few weeks if they have anymore good PR's! One downer for me is the pullback of my largest holding in weed stocks MCIG from .23's to a lod in the .17's yesterday closing at .19 but won't be surprised if it doesn't see more profit-taking yet today though I'm ready to see it test .25 soon. And if FSPM can crack test $2.50 today and my SPCB at $6.14 can break over it's recent $6.40 high I'll really be happy!! All the best with happy trading today!!
:)
Also added PLPL + FSPM today....didn't see PLPL and looking for a big move again tomorrow imho...and FSPM $1.98 close looking to break out of consolidating after an explosive run to nearly $3 recently....like both. GL all longs!! tuna
Okay...sold RNN $1.12 so now I can head out...best all!! tuna
Got RNN $1.04 -.56 on a limit order put in earlier today!!! Made out great yesterday on RNN buying at .95 and again at $1.14 and selling for a quick gain on the .95 buy but getting $1.47 on the second buy for a good gain...probably won't leave just yet....over 50 mil. shares traded already today on RNN...it's been a monster run for it recently but just looking for a small gain....or will take a small loss if it comes to that. SPCB back up to $6.24 +.30 still looking good...tuna
Ohhhh...new HOD SPCB $6.30 +.36 but now $6.15 moving all over the place...haha!! Think I'll take the rest of the day off...best of luck all!!! tuna
SPCB $6.18 +.24 moving up again with a decent market...riding for double digits or bust on this fast growing company....hehe!! Exited FSPM and MJNA for smallish gain....holding MCIG for longer term also like SPCB!! And still in GLUU too, but that's my only holdings for the moment. Best of luck all!! tuna
On an otherwise nasty day 14 of the 16 WEED stocks I follow and trade were "GREEN" today!! (I don't have any sub-pennies on my list). What a difference a day makes....we'll see if the momentum follows through tomorrow! Have a good night all....tuna
Thanks for MEDT case number!! what a strong comeback for the WEEDS after the 2 day big time hit!! Very encouraged for further upside....GL...tuna
WEEDS...MCIG .234 HOD and FSPM $1.51 up from $1.03 LOD....WEEDS look strong for next week imho so held all....disappointing drop in SPCB back under $6 after breaking $6.50 and I'm all in but looking forward still believe it may become a double digit stock yet this year....my guess anyway! GL all...tuna
Another weed stock closing at HOD....MCIG .234 and FSPM strong at $1.51 +.25 up from $1.03 LOD...could bode well for the weeds next week imho...gl all!! tuna
Sounds exciting on SEEK Blullish....thanks for the heads up!! GL...tuna